Amid the fallout over the $1.2 million payments to President Trump’s personal attorney, Novartis is trying to move quickly to contain the damage.

In the past 24 hours, the drug maker’s former chief executive publicly accepted responsibility for faulty judgment in trying to gain access to the Trump administration. And the chief lawyer has resigned for being a party to the contract signed with Michael Cohen.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • May I observe that patience is needed following the links? The pdf file is large (47 pages) and, I suspect, a bit popular so “just wait.” Your time spent will be rewarded. and “Well done” to our scribe!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy